首页> 美国卫生研究院文献>Journal of the Korean Association of Oral and Maxillofacial Surgeons >Prostate adenocarcinoma mandibular metastasis associated with numb chin syndrome: a case report
【2h】

Prostate adenocarcinoma mandibular metastasis associated with numb chin syndrome: a case report

机译:麻木下巴综合征相关的前列腺腺癌下颌转移病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study is to report a rare case of mandibular adenocarcinoma that was diagnosed due to metastasis from the prostate. Numb chin syndrome (NCS), which was associated with this case, is also discussed. Computed tomography (CT) and an intraoral incisional biopsy of the left mandibular area were performed. Urology consultation, hormone therapy, chemotherapy and follow-up radiographic images were administered. Histological examination of the incised specimen revealed moderately differentiated adenocarcinoma. The Gleason score was 8 (primary 4/secondary 4). Immunohistochemical features and radiographic results confirmed the diagnosis of metastasis from prostate adenocarcinoma, moderately differentiated. The patient's prostate-specific antigen (PSA) level was very high. After hormone treatment, the patient's PSA levels dropped gradually. Seventeen months later, in May 2015, the PSA level was elevated. The 18-month follow-up CT image indicated that the patient's condition was aggravated. Docetaxel chemotherapy was started in June 2015 (18 months later), and the sixth cycle of the therapy is in progress. Oral metastases that originate from prostate adenocarcinoma are rare and can induce various periosteal reactions. Hormone therapy, chemotherapy and close follow-up could be additional, appropriate treatment, and were applied in this case. Finally, NCS is a valuable indicator of metastatic disease in the mandible.
机译:本研究的目的是报告因前列腺转移而诊断出的罕见下颌腺癌病例。还讨论了与此病例有关的麻木下巴综合征(NCS)。进行计算机断层扫描(CT)和左下颌骨区域的口内切开活检。进行了泌尿科咨询,激素治疗,化学疗法和后续的放射影像学检查。切开的标本的组织学检查显示中分化腺癌。格里森得分为8(小学4 /中学4)。免疫组织化学特征和影像学结果证实了中度分化的前列腺腺癌转移的诊断。患者的前列腺特异性抗原(PSA)水平很高。激素治疗后,患者的PSA水平逐渐下降。 17个月后,即2015年5月,PSA水平升高。 18个月的随访CT图像表明患者的病情加重。多西他赛化疗于2015年6月(18个月后)开始,目前正在进行第六周期的治疗。源于前列腺腺癌的口腔转移很少见,可诱发各种骨膜反应。激素治疗,化学疗法和密切随访可能是额外的,适当的治疗方法,并且在这种情况下得以应用。最后,NCS是下颌骨转移性疾病的重要指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号